Publications by authors named "Sarala Sarah"

Claim this Profile
R
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models.
Eduardo Huarte, Michael Peel, Ashish Juvekar, Philip Dubé, Sarala Sarah

Immunotherapy· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases.
Maryanne Covington, Xin He, Monika Scuron, Jun Li, Robert Collins, Sarala Sarah

Eur J Pharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Basic Helix-Loop-Helix Gene Nato3 Drives Expression of Dopaminergic Neuron Transcription Factors in Neural Progenitors.
Doug J Peterson, Darcy N Marckini, Jordan L Straight, Elizabeth M King, William Johnson, Sarala S Sarah

Neuroscience· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis